Antai Wang

Wang, Antai, & Zhang, Yilong, & Shao, Yongzhao (2017). On the likelihood of mixture cure models. Statistics and Probability Letters, 131, 51-55.

Wang, Antai, & Chandra, Krishnendu, & Xu, Ruihua, & Sun, Junfeng (2015). The Identifiability of Competing Risks Models induced by Bivariate Frailty Models. Scandinavian Journal of Statistics, Theory and Applications, 42(2), 427-437.

Kalinsky, K, & Lim, EA, & Andreopoulou , E, & Jin, Z, & Desai, AM, & Tu, Y, & Hibshoosh, H, & Wang, Antai, & Greenlee, H, & Crew, KD, & Maurer, M, & Sparano, JA, & Hershman, DL (2014). Increased Expression of Tumor Proliferation Genes in Hispanic Women with Early-Stage Breast Cancer. Cancer Investigation , 32, 439-44.

Wang, Antai (2014). Properties of the Marginal Survival Functions for Dependent Censored Data under an assumed Archimedean Copula. Journal of Multivariate Analysis, 129, 57-68.

Duong, HQ, & Yi, YW, & Kang, HJ, & Hong, YB, & Tang, W, & Wang, Antai, & Seong, YS, & Bae, I (2014). Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine. International Journal of Oncology , 44, 959-69.

Crew, KD, & Wang, Antai, & Hershman, DL (2014). Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signaling in women with hormone receptor-negative breast cancer. Journal of Human Nutrition and Dietetics ,

O'Bryan, K, & Sherman, W, & Niedt, GW, & Taback, B, & Monolidis, S, & Wang, Antai, & Ratner, D (2013). An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma. Journal of American Academy of Dermotology, 69(4), 595-602.

Shen, Jing, & Wang, Antai, & Wang, Q, & Gurvich, I, & Siegel, AB, & Remotti, H, & Santella, RM (2013). Exploration of genome-wide circulating microRNA in Hepatocellular carcinoma : MiR-483-5p as a Potential Biomarker. Cancer Epidemiology, Biomarkers & Prevention, 22, 2364-73.

Yi, YW, & Kang, HJ, & Kim, HJ, & Hwang, JS, & Wang, Antai, & Bae, I (2013). Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells . Molecular Carcinogenesis , 52(9), 667-675.

Kang, HJ, & Hong, Bin, & Weon, Yi Y, & Cho, CH, & Wang, Antai, & Bae, Insoo (2013). The correlations between BRCA1 defect and environmental factors in the risk of breast cancer. Journal of Toxicological Sciences, 38, 355-361.

Yi, YW, & Hong, W, & Kang, HJ, & Kim, HJ, & Zhao, W, & Wang, Antai, & Seong, YS, & Insoo, Bae (2013). Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells. Journal of Cellular and Molecular Medicine , 17(5), 648-656.

Liou, Peter, & Bader, Leah, & Wang, Antai, & Darrell, Yamashiro, & Jessica J, Kandel (2013). Correlation of tumor-associated macrophages and clinicopathological factors in Wilms tumor. Vascular Cell, 5(5),